![]() | Only 14 pages are availabe for public view |
Abstract Optimal perioperative pain control in spine surgeries allows for faster recovery, short hospital stay, reduced complications and improved patient satisfaction. Multimodal analgesia is important strategy in reducing Perioperative pain and decreasing the stress response to surgery. Spine surgeries are mostly associated with severe bleeding which has a significant impact on patient morbidity and length of surgery. Control of blood loss helps to maintain patient’s hemodynamics and also in creating a blood-free field with a good vision for the surgeon. The bleeding is particularly sensitive in spine surgeries, because of proximity to important neural structures which are highly fragile. Controlled hypotension is a technique wherein the arterial blood pressure is lowered in a deliberate but controllable manner to minimize surgical blood loss and enhance the operative field visibility to reduce the overall duration of surgery and anesthesia. There are several pharmacological and non-pharmacological techniques of inducing hypotension, the mechanical ones being tourniquets, table positioning, and intermittent positive pressure ventilation. Nitroglycerin can achieve its hypotensive effect by its vasodilatory effect on arterial and venous bed resulting finally in decreased venous and right heart filling and so decreased cardiac output. Nitroglycerine causes either no change or slight tachycardia during continuous infusion as slight increase in heart rate is reflex phenomenon, baroreceptor response secondary to hypotension produced. Intra venous magnesium sulphate may be a good agent for deliberate hypotension because magnesium intervenes in the activation of membrane Ca ATPase and Na–K ATPase involved in transmembrane ion Summary 69 exchanges during depolarization and repolarization phases, and thus act as a stabilizer of cell membrane and intracytoplasmic organelles. The antagonist effect of magnesium at N-methyl-D-aspartate (NMDA) receptors has led to studies of its adjuvant effect in perioperative analgesia. Dexmedetomidine (DEX) is a potent highly selective α2 adrenergic agonist, possessing a differential specificity for the α2: α1 receptors. DEX has sedative, analgesic, anesthetic sparing effect, and sympatholytic properties. The central and peripheral sympatholytic action of DEX is mediated by α2 adrenergic receptors and is manifested by dose-dependent decrease in arterial blood pressure, heart rate, cardiac output and norepinephrine release. Our study demonstrates that using dexmedetomidine as a hypotensive agent shows decrease the number of patients who need an intraoperative analgesic requirements at different periods of follow up, there was a highly significant increase in group nitroglycerine for need for intraoperative analgesic followed by group magnesium sulphate and group dexmedetomidine showed the lowest need for intraoperative analgesic. The hemodynamics data showed a significant increase in mean arterial blood pressure and heart rate in group nitroglycerine, followed by group magnesium sulphate and the lowest group was dexmedetomidine. Also, the sedation score was significantly higher in group dexmedetomidine more than group nitroglycerine and magnesium sulphate. The speed of recovery was significantly higher in group dexmedetomidine more than group nitroglycerine and magnesium sulphate. The first call for analgesic was significantly higher in group |